NAFLD: Mechanisms, Treatments, and Biomarkers
Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic-associated fatty liver disease (MAFLD), is one of the most common causes of liver diseases worldwide. NAFLD is growing in parallel with the obesity epidemic. No pharmacological treatment is available to treat NAFLD, specifically. T...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2022-06-01
|
| シリーズ: | Biomolecules |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2218-273X/12/6/824 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|